Overview

Immune Dysfunction in Allergic Asthma

Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
We are using anti-IgE to investigate the role of pulmonary mast cells in asthma.
Phase:
N/A
Details
Lead Sponsor:
University of New Mexico
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Omalizumab